跳至主要内容
临床试验/NCT07655466
NCT07655466已完成不适用

Effects of Seed Cycling Capsules on Premenstrual Syndrome Symptoms and Menstrual Cycle Length

Superlune Inc. d/b/a Two Moons Health1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1

研究概览

简要总结

This virtual, single-arm clinical trial will evaluate the effects of Seed Cycling Capsules on symptoms associated with premenstrual syndrome (PMS) and menstrual cycle characteristics. Forty female participants aged 18 to 45 years will use the study products daily for two menstrual cycles. Participants will complete questionnaires at baseline, at the end of their period during Cycle 1, and at the end of their period during Cycle 2.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Be female.
  • Be 18-45 years of age.
  • Have experienced at least five of the following symptoms during the last three menstrual cycles:
  • Heavy flow Prolonged, shortened, or irregular periods Headaches or migraines Low mood Fatigue Bloating Premenstrual or menstrual cramps Breast tenderness Poor sleep Constipation or diarrhea Weight gain or fluctuations Irritability or anger Sick days or reduced social activity due to menstrual symptoms Hormonal acne
  • Be generally healthy.
  • Have a menstrual cycle length between 23 and 35 days.
  • Track menstrual cycles and be able to predict period dates.
  • Be willing to refrain from taking products, medications, or supplements targeting menstrual health during the study.

排除标准

  • Use of hormonal contraception.
  • Allergy to sesame.
  • Chronic conditions that would interfere with study participation, including oncological and psychiatric disorders.
  • Pregnant, breastfeeding, or trying to conceive.
  • Unwillingness to follow the protocol.
  • Menopause or menopausal symptoms.
  • Recent or planned invasive medical procedures.
  • History of substance abuse.
  • Diabetes or other endocrine-related conditions.
  • Current or planned participation in another research study.
  • Use of hormone-modulating medications or therapies.
  • Planned insertion or replacement of an IUD within 12 weeks.
  • Diagnosis of endometriosis, polycystic ovary syndrome (PCOS), or adenomyosis.

研究者

发起方
Superlune Inc. d/b/a Two Moons Health
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验